{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:45:00Z","timestamp":1790516700438,"version":"4.1.0"},"publisher-location":"Singapore","reference-count":71,"publisher":"Springer Singapore","isbn-type":[{"value":"9789811072291","type":"print"},{"value":"9789811072307","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-981-10-7230-7_18","type":"book-chapter","created":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T10:29:29Z","timestamp":1528799369000},"page":"395-412","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Encyclopedia of EBV-Encoded Lytic Genes: An Update"],"prefix":"10.1007","author":[{"given":"Takayuki","family":"Murata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,13]]},"reference":[{"issue":"12","key":"18_CR1","doi-asserted-by":"publisher","first-page":"e404","DOI":"10.1371\/journal.pbio.0030404","volume":"3","author":"M Altmann","year":"2005","unstructured":"Altmann M, Hammerschmidt W (2005) Epstein-Barr virus provides a new paradigm: a requirement for the immediate inhibition of apoptosis. PLoS Biol 3(12):e404. https:\/\/doi.org\/10.1371\/journal.pbio.0030404","journal-title":"PLoS Biol"},{"issue":"2","key":"18_CR2","doi-asserted-by":"publisher","first-page":"851","DOI":"10.4049\/jimmunol.182.2.851","volume":"182","author":"ME Ariza","year":"2009","unstructured":"Ariza ME, Glaser R, Kaumaya PT, Jones C, Williams MV (2009) The EBV-encoded dUTPase activates NF-kappa B through the TLR2 and MyD88-dependent signaling pathway. J Immunol 182(2):851\u2013859","journal-title":"J Immunol"},{"issue":"21","key":"18_CR3","doi-asserted-by":"publisher","first-page":"12825","DOI":"10.1128\/JVI.02139-14","volume":"88","author":"V Aubry","year":"2014","unstructured":"Aubry V, Mure F, Mariame B, Deschamps T, Wyrwicz LS, Manet E, Gruffat H (2014) Epstein-Barr virus late gene transcription depends on the assembly of a virus-specific preinitiation complex. J Virol 88(21):12825\u201312838. https:\/\/doi.org\/10.1128\/JVI.02139-14","journal-title":"J Virol"},{"issue":"10","key":"18_CR4","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/ng1424","volume":"36","author":"PM Bhende","year":"2004","unstructured":"Bhende PM, Seaman WT, Delecluse HJ, Kenney SC (2004) The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome. Nat Genet 36(10):1099\u20131104. https:\/\/doi.org\/10.1038\/ng1424","journal-title":"Nat Genet"},{"issue":"9","key":"18_CR5","doi-asserted-by":"crossref","first-page":"7577","DOI":"10.1128\/JVI.72.9.7577-7582.1998","volume":"72","author":"CM Borza","year":"1998","unstructured":"Borza CM, Hutt-Fletcher LM (1998) Epstein-Barr virus recombinant lacking expression of glycoprotein gp150 infects B cells normally but is enhanced for infection of epithelial cells. J Virol 72(9):7577\u20137582","journal-title":"J Virol"},{"issue":"18","key":"18_CR6","doi-asserted-by":"publisher","first-page":"9647","DOI":"10.1128\/JVI.01126-12","volume":"86","author":"YF Chiu","year":"2012","unstructured":"Chiu YF, Sugden B, Chang PJ, Chen LW, Lin YJ, Lan YC, Lai CH, Liou JY, Liu ST, Hung CH (2012) Characterization and intracellular trafficking of Epstein-Barr virus BBLF1, a protein involved in virion maturation. J Virol 86(18):9647\u20139655. https:\/\/doi.org\/10.1128\/JVI.01126-12","journal-title":"J Virol"},{"issue":"9","key":"18_CR7","doi-asserted-by":"publisher","first-page":"4962","DOI":"10.1128\/JVI.00063-14","volume":"88","author":"SH Chiu","year":"2014","unstructured":"Chiu SH, Wu MC, Wu CC, Chen YC, Lin SF, Hsu JT, Yang CS, Tsai CH, Takada K, Chen MR, Chen JY (2014) Epstein-Barr virus BALF3 has nuclease activity and mediates mature virion production during the lytic cycle. J Virol 88(9):4962\u20134975. https:\/\/doi.org\/10.1128\/JVI.00063-14","journal-title":"J Virol"},{"issue":"9","key":"18_CR8","doi-asserted-by":"crossref","first-page":"7627","DOI":"10.1128\/JVI.73.9.7627-7632.1999","volume":"73","author":"JI Cohen","year":"1999","unstructured":"Cohen JI, Lekstrom K (1999) Epstein-Barr virus BARF1 protein is dispensable for B-cell transformation and inhibits alpha interferon secretion from mononuclear cells. J Virol 73(9):7627\u20137632","journal-title":"J Virol"},{"issue":"6","key":"18_CR9","doi-asserted-by":"publisher","first-page":"e1005718","DOI":"10.1371\/journal.ppat.1005718","volume":"12","author":"R Djavadian","year":"2016","unstructured":"Djavadian R, Chiu YF, Johannsen E (2016) An Epstein-Barr virus-encoded protein complex requires an origin of lytic replication in cis to mediate late gene transcription. PLoS Pathog 12(6):e1005718. https:\/\/doi.org\/10.1371\/journal.ppat.1005718","journal-title":"PLoS Pathog"},{"issue":"1","key":"18_CR10","doi-asserted-by":"publisher","first-page":"e53512","DOI":"10.1371\/journal.pone.0053512","volume":"8","author":"M Duarte","year":"2013","unstructured":"Duarte M, Wang L, Calderwood MA, Adelmant G, Ohashi M, Roecklein-Canfield J, Marto JA, Hill DE, Deng H, Johannsen E (2013) An RS motif within the Epstein-Barr virus BLRF2 tegument protein is phosphorylated by SRPK2 and is important for viral replication. PLoS One 8(1):e53512. https:\/\/doi.org\/10.1371\/journal.pone.0053512","journal-title":"PLoS One"},{"issue":"6","key":"18_CR11","doi-asserted-by":"publisher","first-page":"3703","DOI":"10.1128\/JVI.79.6.3703-3712.2005","volume":"79","author":"A Farina","year":"2005","unstructured":"Farina A, Feederle R, Raffa S, Gonnella R, Santarelli R, Frati L, Angeloni A, Torrisi MR, Faggioni A, Delecluse HJ (2005) BFRF1 of Epstein-Barr virus is essential for efficient primary viral envelopment and egress. J Virol 79(6):3703\u20133712. https:\/\/doi.org\/10.1128\/JVI.79.6.3703-3712.2005","journal-title":"J Virol"},{"issue":"12","key":"18_CR12","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1093\/emboj\/19.12.3080","volume":"19","author":"R Feederle","year":"2000","unstructured":"Feederle R, Kost M, Baumann M, Janz A, Drouet E, Hammerschmidt W, Delecluse HJ (2000) The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. EMBO J 19(12):3080\u20133089. https:\/\/doi.org\/10.1093\/emboj\/19.12.3080","journal-title":"EMBO J"},{"issue":"19","key":"18_CR13","doi-asserted-by":"publisher","first-page":"9435","DOI":"10.1128\/JVI.00473-06","volume":"80","author":"R Feederle","year":"2006","unstructured":"Feederle R, Neuhierl B, Baldwin G, Bannert H, Hub B, Mautner J, Behrends U, Delecluse HJ (2006) Epstein-Barr virus BNRF1 protein allows efficient transfer from the endosomal compartment to the nucleus of primary B lymphocytes. J Virol 80(19):9435\u20139443. https:\/\/doi.org\/10.1128\/JVI.00473-06","journal-title":"J Virol"},{"issue":"10","key":"18_CR14","doi-asserted-by":"publisher","first-page":"4952","DOI":"10.1128\/JVI.00170-09","volume":"83","author":"R Feederle","year":"2009","unstructured":"Feederle R, Bannert H, Lips H, Muller-Lantzsch N, Delecluse HJ (2009a) The Epstein-Barr virus alkaline exonuclease BGLF5 serves pleiotropic functions in virus replication. J Virol 83(10):4952\u20134962. https:\/\/doi.org\/10.1128\/JVI.00170-09","journal-title":"J Virol"},{"issue":"21","key":"18_CR15","doi-asserted-by":"publisher","first-page":"10877","DOI":"10.1128\/JVI.00525-09","volume":"83","author":"R Feederle","year":"2009","unstructured":"Feederle R, Mehl-Lautscham AM, Bannert H, Delecluse HJ (2009b) The Epstein-Barr virus protein kinase BGLF4 and the exonuclease BGLF5 have opposite effects on the regulation of viral protein production. J Virol 83(21):10877\u201310891. https:\/\/doi.org\/10.1128\/JVI.00525-09","journal-title":"J Virol"},{"issue":"8","key":"18_CR16","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1128\/JVI.66.8.5030-5039.1992","volume":"66","author":"ED Fixman","year":"1992","unstructured":"Fixman ED, Hayward GS, Hayward SD (1992) trans-acting requirements for replication of Epstein-Barr virus ori-Lyt. J Virol 66(8):5030\u20135039","journal-title":"J Virol"},{"issue":"5","key":"18_CR17","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1128\/JVI.69.5.2998-3006.1995","volume":"69","author":"ED Fixman","year":"1995","unstructured":"Fixman ED, Hayward GS, Hayward SD (1995) Replication of Epstein-Barr virus oriLyt: lack of a dedicated virally encoded origin-binding protein and dependence on Zta in cotransfection assays. J Virol 69(5):2998\u20133006","journal-title":"J Virol"},{"issue":"4","key":"18_CR18","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/ncb2035","volume":"12","author":"S Gastaldello","year":"2010","unstructured":"Gastaldello S, Hildebrand S, Faridani O, Callegari S, Palmkvist M, Di Guglielmo C, Masucci MG (2010) A deneddylase encoded by Epstein-Barr virus promotes viral DNA replication by regulating the activity of cullin-RING ligases. Nat Cell Biol 12(4):351\u2013361. https:\/\/doi.org\/10.1038\/ncb2035","journal-title":"Nat Cell Biol"},{"issue":"6","key":"18_CR19","doi-asserted-by":"publisher","first-page":"3713","DOI":"10.1128\/JVI.79.6.3713-3727.2005","volume":"79","author":"R Gonnella","year":"2005","unstructured":"Gonnella R, Farina A, Santarelli R, Raffa S, Feederle R, Bei R, Granato M, Modesti A, Frati L, Delecluse HJ, Torrisi MR, Angeloni A, Faggioni A (2005) Characterization and intracellular localization of the Epstein-Barr virus protein BFLF2: interactions with BFRF1 and with the nuclear lamina. J Virol 79(6):3713\u20133727. https:\/\/doi.org\/10.1128\/JVI.79.6.3713-3727.2005","journal-title":"J Virol"},{"issue":"1","key":"18_CR20","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.virol.2008.10.010","volume":"383","author":"M Gore","year":"2009","unstructured":"Gore M, Hutt-Fletcher LM (2009) The BDLF2 protein of Epstein-Barr virus is a type II glycosylated envelope protein whose processing is dependent on coexpression with the BMRF2 protein. Virology 383(1):162\u2013167. https:\/\/doi.org\/10.1016\/j.virol.2008.10.010","journal-title":"Virology"},{"issue":"4","key":"18_CR21","doi-asserted-by":"publisher","first-page":"e1005550","DOI":"10.1371\/journal.ppat.1005550","volume":"12","author":"AM Gram","year":"2016","unstructured":"Gram AM, Oosenbrug T, Lindenbergh MF, Bull C, Comvalius A, Dickson KJ, Wiegant J, Vrolijk H, Lebbink RJ, Wolterbeek R, Adema GJ, Griffioen M, Heemskerk MH, Tscharke DC, Hutt-Fletcher LM, Wiertz EJ, Hoeben RC, Ressing ME (2016) The Epstein-Barr virus glycoprotein gp150 forms an immune-evasive glycan shield at the surface of infected cells. PLoS Pathog 12(4):e1005550. https:\/\/doi.org\/10.1371\/journal.ppat.1005550","journal-title":"PLoS Pathog"},{"issue":"19","key":"18_CR22","doi-asserted-by":"publisher","first-page":"9635","DOI":"10.1128\/JVI.76.19.9635-9644.2002","volume":"76","author":"H Gruffat","year":"2002","unstructured":"Gruffat H, Batisse J, Pich D, Neuhierl B, Manet E, Hammerschmidt W, Sergeant A (2002) Epstein-Barr virus mRNA export factor EB2 is essential for production of infectious virus. J Virol 76(19):9635\u20139644","journal-title":"J Virol"},{"issue":"11","key":"18_CR23","doi-asserted-by":"publisher","first-page":"6023","DOI":"10.1128\/JVI.00159-12","volume":"86","author":"H Gruffat","year":"2012","unstructured":"Gruffat H, Kadjouf F, Mariame B, Manet E (2012) The Epstein-Barr virus BcRF1 gene product is a TBP-like protein with an essential role in late gene expression. J Virol 86(11):6023\u20136032. https:\/\/doi.org\/10.1128\/JVI.00159-12","journal-title":"J Virol"},{"issue":"3","key":"18_CR24","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/0092-8674(88)90028-1","volume":"55","author":"W Hammerschmidt","year":"1988","unstructured":"Hammerschmidt W, Sugden B (1988) Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus. Cell 55(3):427\u2013433","journal-title":"Cell"},{"issue":"9","key":"18_CR25","doi-asserted-by":"publisher","first-page":"5151","DOI":"10.1128\/JVI.06760-11","volume":"86","author":"AM Heilmann","year":"2012","unstructured":"Heilmann AM, Calderwood MA, Portal D, Lu Y, Johannsen E (2012) Genome-wide analysis of Epstein-Barr virus Rta DNA binding. J Virol 86(9):5151\u20135164. https:\/\/doi.org\/10.1128\/JVI.06760-11","journal-title":"J Virol"},{"issue":"8","key":"18_CR26","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1128\/JVI.01733-08","volume":"83","author":"BW Henson","year":"2009","unstructured":"Henson BW, Perkins EM, Cothran JE, Desai P (2009) Self-assembly of Epstein-Barr virus capsids. J Virol 83(8):3877\u20133890. https:\/\/doi.org\/10.1128\/JVI.01733-08","journal-title":"J Virol"},{"issue":"8","key":"18_CR27","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1084\/jem.20070256","volume":"204","author":"AD Hislop","year":"2007","unstructured":"Hislop AD, Ressing ME, van Leeuwen D, Pudney VA, Horst D, Koppers-Lalic D, Croft NP, Neefjes JJ, Rickinson AB, Wiertz EJ (2007) A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates. J Exp Med 204(8):1863\u20131873. https:\/\/doi.org\/10.1084\/jem.20070256","journal-title":"J Exp Med"},{"issue":"21","key":"18_CR28","doi-asserted-by":"publisher","first-page":"10142","DOI":"10.1128\/JVI.74.21.10142-10152.2000","volume":"74","author":"A Janz","year":"2000","unstructured":"Janz A, Oezel M, Kurzeder C, Mautner J, Pich D, Kost M, Hammerschmidt W, Delecluse HJ (2000) Infectious Epstein-Barr virus lacking major glycoprotein BLLF1 (gp350\/220) demonstrates the existence of additional viral ligands. J Virol 74(21):10142\u201310152","journal-title":"J Virol"},{"issue":"5","key":"18_CR29","doi-asserted-by":"publisher","first-page":"e1002704","DOI":"10.1371\/journal.ppat.1002704","volume":"8","author":"S Jochum","year":"2012","unstructured":"Jochum S, Moosmann A, Lang S, Hammerschmidt W, Zeidler R (2012) The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination. PLoS Pathog 8(5):e1002704. https:\/\/doi.org\/10.1371\/journal.ppat.1002704","journal-title":"PLoS Pathog"},{"issue":"46","key":"18_CR30","doi-asserted-by":"publisher","first-page":"16286","DOI":"10.1073\/pnas.0407320101","volume":"101","author":"E Johannsen","year":"2004","unstructured":"Johannsen E, Luftig M, Chase MR, Weicksel S, Cahir-McFarland E, Illanes D, Sarracino D, Kieff E (2004) Proteins of purified Epstein-Barr virus. Proc Natl Acad Sci U S A 101(46):16286\u201316291. https:\/\/doi.org\/10.1073\/pnas.0407320101","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"18_CR31","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1073\/pnas.0911948107","volume":"107","author":"M Kalla","year":"2010","unstructured":"Kalla M, Schmeinck A, Bergbauer M, Pich D, Hammerschmidt W (2010) AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome. Proc Natl Acad Sci U S A 107(2):850\u2013855. https:\/\/doi.org\/10.1073\/pnas.0911948107","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"18_CR32","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/jmv.23208","volume":"84","author":"KR Katsumura","year":"2012","unstructured":"Katsumura KR, Maruo S, Takada K (2012) EBV lytic infection enhances transformation of B-lymphocytes infected with EBV in the presence of T-lymphocytes. J Med Virol 84(3):504\u2013510. https:\/\/doi.org\/10.1002\/jmv.23208","journal-title":"J Med Virol"},{"issue":"11","key":"18_CR33","doi-asserted-by":"publisher","first-page":"6482","DOI":"10.1128\/JVI.03428-12","volume":"87","author":"D Kawashima","year":"2013","unstructured":"Kawashima D, Kanda T, Murata T, Saito S, Sugimoto A, Narita Y, Tsurumi T (2013) Nuclear transport of Epstein-Barr virus DNA polymerase is dependent on the BMRF1 polymerase processivity factor and molecular chaperone Hsp90. J Virol 87(11):6482\u20136491. https:\/\/doi.org\/10.1128\/JVI.03428-12","journal-title":"J Virol"},{"issue":"3","key":"18_CR34","doi-asserted-by":"publisher","first-page":"e1000341","DOI":"10.1371\/journal.ppat.1000341","volume":"5","author":"GL Kelly","year":"2009","unstructured":"Kelly GL, Long HM, Stylianou J, Thomas WA, Leese A, Bell AI, Bornkamm GW, Mautner J, Rickinson AB, Rowe M (2009) An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp\/BHRF1 link. PLoS Pathog 5(3):e1000341. https:\/\/doi.org\/10.1371\/journal.ppat.1000341","journal-title":"PLoS Pathog"},{"issue":"21","key":"18_CR35","doi-asserted-by":"publisher","first-page":"4996","DOI":"10.1128\/MCB.00600-10","volume":"30","author":"GR Kumar","year":"2010","unstructured":"Kumar GR, Glaunsinger BA (2010) Nuclear import of cytoplasmic poly(A) binding protein restricts gene expression via hyperadenylation and nuclear retention of mRNA. Mol Cell Biol 30(21):4996\u20135008. https:\/\/doi.org\/10.1128\/MCB.00600-10","journal-title":"Mol Cell Biol"},{"issue":"23","key":"18_CR36","doi-asserted-by":"publisher","first-page":"11162","DOI":"10.1128\/JVI.74.23.11162-11172.2000","volume":"74","author":"CM Lake","year":"2000","unstructured":"Lake CM, Hutt-Fletcher LM (2000) Epstein-Barr virus that lacks glycoprotein gN is impaired in assembly and infection. J Virol 74(23):11162\u201311172","journal-title":"J Virol"},{"issue":"5","key":"18_CR37","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1128\/JVI.02942-15","volume":"90","author":"MB Latif","year":"2015","unstructured":"Latif MB, Machiels B, Xiao X, Mast J, Vanderplasschen A, Gillet L (2015) Deletion of murid herpesvirus 4 ORF63 affects the trafficking of incoming capsids toward the nucleus. J Virol 90(5):2455\u20132472. https:\/\/doi.org\/10.1128\/JVI.02942-15","journal-title":"J Virol"},{"issue":"2","key":"18_CR38","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1128\/JVI.01410-15","volume":"90","author":"X Liu","year":"2016","unstructured":"Liu X, Cohen JI (2016) Epstein-Barr virus (EBV) tegument protein BGLF2 promotes EBV reactivation through activation of the p38 mitogen-activated protein kinase. J Virol 90(2):1129\u20131138. https:\/\/doi.org\/10.1128\/JVI.01410-15","journal-title":"J Virol"},{"issue":"23","key":"18_CR01","doi-asserted-by":"publisher","first-page":"e00975-17","DOI":"10.1128\/JVI.00975-17","volume":"91","author":"HMA Masud","year":"2017","unstructured":"Masud HMA, Watanabe T, Yoshida M, Sato Y, Goshima F, Kimura H, Murata T (2017) Epstein-Barr virus BKRF4 gene product is required for efficient progeny production. J Virol 91(23):e00975-17","journal-title":"J Virol"},{"issue":"9","key":"18_CR39","doi-asserted-by":"publisher","first-page":"4534","DOI":"10.1128\/JVI.02487-09","volume":"84","author":"Q Meng","year":"2010","unstructured":"Meng Q, Hagemeier SR, Fingeroth JD, Gershburg E, Pagano JS, Kenney SC (2010) The Epstein-Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral production. J Virol 84(9):4534\u20134542. https:\/\/doi.org\/10.1128\/JVI.02487-09","journal-title":"J Virol"},{"issue":"1\u20132","key":"18_CR40","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.virol.2009.04.007","volume":"389","author":"T Murata","year":"2009","unstructured":"Murata T, Isomura H, Yamashita Y, Toyama S, Sato Y, Nakayama S, Kudoh A, Iwahori S, Kanda T, Tsurumi T (2009) Efficient production of infectious viruses requires enzymatic activity of Epstein-Barr virus protein kinase. Virology 389(1\u20132):75\u201381. https:\/\/doi.org\/10.1016\/j.virol.2009.04.007","journal-title":"Virology"},{"issue":"18","key":"18_CR41","doi-asserted-by":"publisher","first-page":"10148","DOI":"10.1128\/JVI.01002-13","volume":"87","author":"T Murata","year":"2013","unstructured":"Murata T, Narita Y, Sugimoto A, Kawashima D, Kanda T, Tsurumi T (2013) Contribution of myocyte enhancer factor 2 family transcription factors to BZLF1 expression in Epstein-Barr virus reactivation from latency. J Virol 87(18):10148\u201310162. https:\/\/doi.org\/10.1128\/JVI.01002-13","journal-title":"J Virol"},{"issue":"51","key":"18_CR42","doi-asserted-by":"publisher","first-page":"35896","DOI":"10.1074\/jbc.M109.051581","volume":"284","author":"K Murayama","year":"2009","unstructured":"Murayama K, Nakayama S, Kato-Murayama M, Akasaka R, Ohbayashi N, Kamewari-Hayami Y, Terada T, Shirouzu M, Tsurumi T, Yokoyama S (2009) Crystal structure of Epstein-Barr virus DNA polymerase processivity factor BMRF1. J Biol Chem 284(51):35896\u201335905. https:\/\/doi.org\/10.1074\/jbc.M109.051581","journal-title":"J Biol Chem"},{"issue":"24","key":"18_CR43","doi-asserted-by":"publisher","first-page":"12589","DOI":"10.1128\/JVI.01394-10","volume":"84","author":"S Nakayama","year":"2010","unstructured":"Nakayama S, Murata T, Yasui Y, Murayama K, Isomura H, Kanda T, Tsurumi T (2010) Tetrameric ring formation of Epstein-Barr virus polymerase processivity factor is crucial for viral replication. J Virol 84(24):12589\u201312598. https:\/\/doi.org\/10.1128\/JVI.01394-10","journal-title":"J Virol"},{"issue":"38","key":"18_CR44","doi-asserted-by":"publisher","first-page":"29632","DOI":"10.1074\/jbc.M110.115618","volume":"285","author":"S Nijmeijer","year":"2010","unstructured":"Nijmeijer S, Leurs R, Smit MJ, Vischer HF (2010) The Epstein-Barr virus-encoded G protein-coupled receptor BILF1 hetero-oligomerizes with human CXCR4, scavenges Galphai proteins, and constitutively impairs CXCR4 functioning. J Biol Chem 285(38):29632\u201329641. https:\/\/doi.org\/10.1074\/jbc.M110.115618","journal-title":"J Biol Chem"},{"issue":"1","key":"18_CR45","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.virol.2010.06.007","volume":"405","author":"KJ O\u2019Regan","year":"2010","unstructured":"O\u2019Regan KJ, Brignati MJ, Murphy MA, Bucks MA, Courtney RJ (2010) Virion incorporation of the herpes simplex virus type 1 tegument protein VP22 is facilitated by trans-Golgi network localization and is independent of interaction with glycoprotein E. Virology 405(1):176\u2013192. https:\/\/doi.org\/10.1016\/j.virol.2010.06.007","journal-title":"Virology"},{"issue":"4","key":"18_CR46","doi-asserted-by":"publisher","first-page":"e92593","DOI":"10.1371\/journal.pone.0092593","volume":"9","author":"R Park","year":"2014","unstructured":"Park R, El-Guindy A, Heston L, Lin SF, Yu KP, Nagy M, Borah S, Delecluse HJ, Steitz J, Miller G (2014) Nuclear translocation and regulation of intranuclear distribution of cytoplasmic poly(A)-binding protein are distinct processes mediated by two Epstein Barr virus proteins. PLoS One 9(4):e92593. https:\/\/doi.org\/10.1371\/journal.pone.0092593","journal-title":"PLoS One"},{"issue":"4","key":"18_CR47","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1128\/JVI.02533-12","volume":"87","author":"S Pavlova","year":"2013","unstructured":"Pavlova S, Feederle R, Gartner K, Fuchs W, Granzow H, Delecluse HJ (2013) An Epstein-Barr virus mutant produces immunogenic defective particles devoid of viral DNA. J Virol 87(4):2011\u20132022. https:\/\/doi.org\/10.1128\/JVI.02533-12","journal-title":"J Virol"},{"issue":"1","key":"18_CR48","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1128\/JVI.02183-15","volume":"90","author":"LL Quinn","year":"2016","unstructured":"Quinn LL, Williams LR, White C, Forrest C, Zuo J, Rowe M (2016) The missing link in Epstein-Barr virus immune evasion: the BDLF3 gene induces ubiquitination and downregulation of major histocompatibility complex class I (MHC-I) and MHC-II. J Virol 90(1):356\u2013367. https:\/\/doi.org\/10.1128\/JVI.02183-15","journal-title":"J Virol"},{"issue":"6","key":"18_CR49","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1128\/JVI.02175-10","volume":"85","author":"AJ Rennekamp","year":"2011","unstructured":"Rennekamp AJ, Lieberman PM (2011) Initiation of Epstein-Barr virus lytic replication requires transcription and the formation of a stable RNA-DNA hybrid molecule at OriLyt. J Virol 85(6):2837\u20132850. https:\/\/doi.org\/10.1128\/JVI.02175-10","journal-title":"J Virol"},{"issue":"9","key":"18_CR50","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1073\/pnas.0611128104","volume":"104","author":"M Rowe","year":"2007","unstructured":"Rowe M, Glaunsinger B, van Leeuwen D, Zuo J, Sweetman D, Ganem D, Middeldorp J, Wiertz EJ, Ressing ME (2007) Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion. Proc Natl Acad Sci U S A 104(9):3366\u20133371. https:\/\/doi.org\/10.1073\/pnas.0611128104","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"18_CR51","doi-asserted-by":"publisher","first-page":"4060","DOI":"10.1128\/JVI.02020-12","volume":"87","author":"S Saito","year":"2013","unstructured":"Saito S, Murata T, Kanda T, Isomura H, Narita Y, Sugimoto A, Kawashima D, Tsurumi T (2013) Epstein-Barr virus deubiquitinase downregulates TRAF6-mediated NF-kappaB signaling during productive replication. J Virol 87(7):4060\u20134070. https:\/\/doi.org\/10.1128\/JVI.02020-12","journal-title":"J Virol"},{"issue":"10","key":"18_CR52","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1002\/j.1460-2075.1993.tb06070.x","volume":"12","author":"A Schepers","year":"1993","unstructured":"Schepers A, Pich D, Hammerschmidt W (1993) A transcription factor with homology to the AP-1 family links RNA transcription and DNA replication in the lytic cycle of Epstein-Barr virus. EMBO J 12(10):3921\u20133929","journal-title":"EMBO J"},{"issue":"6","key":"18_CR53","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1128\/JVI.77.6.3859-3865.2003","volume":"77","author":"W Sheng","year":"2003","unstructured":"Sheng W, Decaussin G, Ligout A, Takada K, Ooka T (2003) Malignant transformation of Epstein-Barr virus-negative Akata cells by introduction of the BARF1 gene carried by Epstein-Barr virus. J Virol 77(6):3859\u20133865","journal-title":"J Virol"},{"issue":"Pt 8","key":"18_CR54","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1099\/vir.0.19112-0","volume":"84","author":"AJ Sinclair","year":"2003","unstructured":"Sinclair AJ (2003) bZIP proteins of human gammaherpesviruses. J Gen Virol 84(Pt 8):1941\u20131949. https:\/\/doi.org\/10.1099\/vir.0.19112-0","journal-title":"J Gen Virol"},{"issue":"10","key":"18_CR55","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.1073\/pnas.0404521102","volume":"102","author":"MJ Song","year":"2005","unstructured":"Song MJ, Hwang S, Wong WH, Wu TT, Lee S, Liao HI, Sun R (2005) Identification of viral genes essential for replication of murine gamma-herpesvirus 68 using signature-tagged mutagenesis. Proc Natl Acad Sci U S A 102(10):3805\u20133810. https:\/\/doi.org\/10.1073\/pnas.0404521102","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"18_CR56","doi-asserted-by":"publisher","first-page":"8883","DOI":"10.1128\/JVI.00950-14","volume":"88","author":"MT Su","year":"2014","unstructured":"Su MT, Liu IH, Wu CW, Chang SM, Tsai CH, Yang PW, Chuang YC, Lee CP, Chen MR (2014) Uracil DNA glycosylase BKRF3 contributes to Epstein-Barr virus DNA replication through physical interactions with proteins in viral DNA replication complex. J Virol 88(16):8883\u20138899. https:\/\/doi.org\/10.1128\/JVI.00950-14","journal-title":"J Virol"},{"issue":"12","key":"18_CR57","doi-asserted-by":"crossref","first-page":"7406","DOI":"10.1128\/JVI.67.12.7406-7413.1993","volume":"67","author":"S Swaminathan","year":"1993","unstructured":"Swaminathan S, Hesselton R, Sullivan J, Kieff E (1993) Epstein-Barr virus recombinants with specifically mutated BCRF1 genes. J Virol 67(12):7406\u20137413","journal-title":"J Virol"},{"issue":"11","key":"18_CR58","doi-asserted-by":"publisher","first-page":"e1002376","DOI":"10.1371\/journal.ppat.1002376","volume":"7","author":"K Tsai","year":"2011","unstructured":"Tsai K, Thikmyanova N, Wojcechowskyj JA, Delecluse HJ, Lieberman PM (2011) EBV tegument protein BNRF1 disrupts DAXX-ATRX to activate viral early gene transcription. PLoS Pathog 7(11):e1002376. https:\/\/doi.org\/10.1371\/journal.ppat.1002376","journal-title":"PLoS Pathog"},{"issue":"5","key":"18_CR59","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1128\/JVI.68.5.3354-3363.1994","volume":"68","author":"T Tsurumi","year":"1994","unstructured":"Tsurumi T, Daikoku T, Nishiyama Y (1994) Further characterization of the interaction between the Epstein-Barr virus DNA polymerase catalytic subunit and its accessory subunit with regard to the 3\u2032-to-5\u2032 exonucleolytic activity and stability of initiation complex at primer terminus. J Virol 68(5):3354\u20133363","journal-title":"J Virol"},{"issue":"Pt 5","key":"18_CR60","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1099\/0022-1317-79-5-1257","volume":"79","author":"T Tsurumi","year":"1998","unstructured":"Tsurumi T, Kishore J, Yokoyama N, Fujita M, Daikoku T, Yamada H, Yamashita Y, Nishiyama Y (1998) Overexpression, purification and helix-destabilizing properties of Epstein-Barr virus ssDNA-binding protein. J Gen Virol 79(Pt 5):1257\u20131264. https:\/\/doi.org\/10.1099\/0022-1317-79-5-1257","journal-title":"J Gen Virol"},{"issue":"1","key":"18_CR61","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/rmv.441","volume":"15","author":"T Tsurumi","year":"2005","unstructured":"Tsurumi T, Fujita M, Kudoh A (2005) Latent and lytic Epstein-Barr virus replication strategies. Rev Med Virol 15(1):3\u201315. https:\/\/doi.org\/10.1002\/rmv.441","journal-title":"Rev Med Virol"},{"issue":"1","key":"18_CR62","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.bbrc.2008.09.082","volume":"377","author":"HF Vischer","year":"2008","unstructured":"Vischer HF, Nijmeijer S, Smit MJ, Leurs R (2008) Viral hijacking of human receptors through heterodimerization. Biochem Biophys Res Commun 377(1):93\u201397. https:\/\/doi.org\/10.1016\/j.bbrc.2008.09.082","journal-title":"Biochem Biophys Res Commun"},{"key":"18_CR63","doi-asserted-by":"publisher","first-page":"6240","DOI":"10.1038\/ncomms7240","volume":"6","author":"HB Wang","year":"2015","unstructured":"Wang HB, Zhang H, Zhang JP, Li Y, Zhao B, Feng GK, Du Y, Xiong D, Zhong Q, Liu WL, Du H, Li MZ, Huang WL, Tsao SW, Hutt-Fletcher L, Zeng YX, Kieff E, Zeng MS (2015) Neuropilin 1 is an entry factor that promotes EBV infection of nasopharyngeal epithelial cells. Nat Commun 6:6240. https:\/\/doi.org\/10.1038\/ncomms7240","journal-title":"Nat Commun"},{"key":"18_CR64","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.virol.2015.04.007","volume":"483","author":"T Watanabe","year":"2015","unstructured":"Watanabe T, Fuse K, Takano T, Narita Y, Goshima F, Kimura H, Murata T (2015a) Roles of Epstein-Barr virus BGLF3.5 gene and two upstream open reading frames in lytic viral replication in HEK293 cells. Virology 483:44\u201353. https:\/\/doi.org\/10.1016\/j.virol.2015.04.007","journal-title":"Virology"},{"issue":"19","key":"18_CR65","doi-asserted-by":"publisher","first-page":"10120","DOI":"10.1128\/JVI.01604-15","volume":"89","author":"T Watanabe","year":"2015","unstructured":"Watanabe T, Narita Y, Yoshida M, Sato Y, Goshima F, Kimura H, Murata T (2015b) The Epstein-Barr virus BDLF4 gene is required for efficient expression of viral late lytic genes. J Virol 89(19):10120\u201310124. https:\/\/doi.org\/10.1128\/JVI.01604-15","journal-title":"J Virol"},{"key":"18_CR66","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.virol.2015.05.010","volume":"484","author":"T Watanabe","year":"2015","unstructured":"Watanabe T, Tsuruoka M, Narita Y, Katsuya R, Goshima F, Kimura H, Murata T (2015c) The Epstein-Barr virus BRRF2 gene product is involved in viral progeny production. Virology 484:33\u201340. https:\/\/doi.org\/10.1016\/j.virol.2015.05.010","journal-title":"Virology"},{"issue":"10","key":"18_CR67","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1002\/j.1460-2075.1989.tb08438.x","volume":"8","author":"MX Wei","year":"1989","unstructured":"Wei MX, Ooka T (1989) A transforming function of the BARF1 gene encoded by Epstein-Barr virus. EMBO J 8(10):2897\u20132903","journal-title":"EMBO J"},{"issue":"5","key":"18_CR68","doi-asserted-by":"publisher","first-page":"e01574","DOI":"10.1128\/mBio.01574-15","volume":"6","author":"CB Whitehurst","year":"2015","unstructured":"Whitehurst CB, Li G, Montgomery SA, Montgomery ND, Su L, Pagano JS (2015) Knockout of Epstein-Barr virus BPLF1 retards B-cell transformation and lymphoma formation in humanized mice. mBio 6(5):e01574\u2013e01515. https:\/\/doi.org\/10.1128\/mBio.01574-15","journal-title":"mBio"},{"issue":"1","key":"18_CR02","doi-asserted-by":"publisher","first-page":"6044","DOI":"10.1038\/s41598-017-06413-7","volume":"7","author":"M Yoshida","year":"2017","unstructured":"Yoshida M, Watanabe T, Narita Y, Sato Y, Goshima F, Kimura H, Murata T (2017) The Epstein-Barr virus BRRF1 gene is dispensable for viral replication in HEK293 cells and transformation. Sci Rep 7(1):6044","journal-title":"Sci Rep"},{"issue":"1","key":"18_CR69","doi-asserted-by":"publisher","first-page":"e1000255","DOI":"10.1371\/journal.ppat.1000255","volume":"5","author":"J Zuo","year":"2009","unstructured":"Zuo J, Currin A, Griffin BD, Shannon-Lowe C, Thomas WA, Ressing ME, Wiertz EJ, Rowe M (2009) The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation. PLoS Pathog 5(1):e1000255. https:\/\/doi.org\/10.1371\/journal.ppat.1000255","journal-title":"PLoS Pathog"}],"container-title":["Advances in Experimental Medicine and Biology","Human Herpesviruses"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-10-7230-7_18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T11:07:09Z","timestamp":1604401629000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-10-7230-7_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9789811072291","9789811072307"],"references-count":71,"URL":"https:\/\/doi.org\/10.1007\/978-981-10-7230-7_18","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}